On February 28, 2024, Fujian Wanchen Biotechnology Group Co., Ltd. closed the transaction. The company issued 17,699,115 A shares at an issue price of CNY 11.30 for the gross proceeds of CNY 199,999,999.5. The company has disclosed the issue expenses of CNY 6,398,393.25 and the net proceeds of the transaction is CNY 193,601,606.75. The transaction included participation from individual investor Wang Zening who have subscribed for all the shares.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.32 CNY | -1.91% | +3.21% | -24.56% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.56% | 676M | |
+18.09% | 1.03B | |
+19.72% | 856M | |
0.00% | 780M | |
-6.97% | 400M | |
+3.40% | 366M | |
-25.05% | 307M | |
-25.42% | 276M | |
-10.14% | 264M | |
-12.75% | 246M |
- Stock Market
- Equities
- 300972 Stock
- News Fujian Wanchen Biotechnology Group Co., Ltd.
- Fujian Wanchen Biotechnology Group Co., Ltd. announced that it has received CNY 200 million in funding